Physical activity: a possible determinant of vincristine (NSC-67574) neuropathy.
D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009461:Neurologic Manifestations; D010292:Paresthesia / Q000139:chemically induced; D005082:Physical Exertion; D013974:Thyroxine / Q000097:blood; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D014750:Vincristine; D003520:Cyclophosphamide; D013974:Thyroxine; D005472:Fluorouracil